This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2018 Oct;15(10):596-597.

doi: 10.1038/s41571-018-0066-3.

Reinforcing the social compromise of accelerated approval

Bishal Gyawali¹, Aaron S Kesselheim²

Affiliations

Affiliations

¹ Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
² Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. akesselheim@bwh.harvard.edu.

PMID: 29970919
DOI: 10.1038/s41571-018-0066-3

Comment

Reinforcing the social compromise of accelerated approval

Bishal Gyawali et al. Nat Rev Clin Oncol. 2018 Oct.

. 2018 Oct;15(10):596-597.

doi: 10.1038/s41571-018-0066-3.

Authors

Bishal Gyawali¹, Aaron S Kesselheim²

Affiliations

¹ Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
² Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. akesselheim@bwh.harvard.edu.

PMID: 29970919
DOI: 10.1038/s41571-018-0066-3

No abstract available

PubMed Disclaimer

Comment on

Fulfillment of Postmarketing Requirements to the FDA for Therapies Granted Oncology Indications Between 2011 and 2016.
Zettler M, Nabhan C. Zettler M, et al. JAMA Oncol. 2018 Jul 1;4(7):993-994. doi: 10.1001/jamaoncol.2018.0610. JAMA Oncol. 2018. PMID: 29801111 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- scite Smart Citations